ResMed (RMD) Misses Q3 EPS by 10c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $226.38 +0.17%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $1.32, $0.10 worse than the analyst estimate of $1.42. Revenue for the quarter came in at $864.5 million versus the consensus estimate of $897.04 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
- Burry doubles down on Nebius short after stock surges 34% on earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
